Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Brian A. Jonas | Researchclopedia

Back to researchers

Brian A. Jonas

University of California Davis Medical Center ORCID

281

Works

9,694

Citations

36

h-index

86

i10-index

Research Topics

Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research

Affiliations

The University of Texas MD Anderson Cancer Center2019–2019

University of Miami2019–2019

GlaxoSmithKline (India)2022–2022

Northern California Research2021–2021

Gilead Sciences (Canada)2022–2022

Top Works

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo,Brian A. Jonas,et al.

20202,668 citations

Multiple Myeloma Research and Treatments

Myeloproliferative Neoplasms: Diagnosis and Treatment

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Courtney D. DiNardo,Keith W. Pratz,et al.

20181,826 citations

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Courtney D. DiNardo,Keith W. Pratz,et al.

2018701 citations

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Jörge E. Cortes,Samer K. Khaled,et al.

2019471 citations

How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia

Brian A. Jonas,Daniel A. Pollyea

2019186 citations

Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia

Keith W. Pratz,Brian A. Jonas,et al.

2024178 citations

Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology

Daniel A. Pollyea,Jessica K. Altman,et al.

2023167 citations

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

Keith W. Pratz,Brian A. Jonas,et al.

2021166 citations

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

Daniel A. Pollyea,Keith W. Pratz,et al.

2020163 citations